Skip to content

POWERPLAY Phase 2: Development and Evaluation in Male-dominated Workplaces

POWERPLAY: Building Employee Health and Safety Through Prevention in Male-dominated Workplaces

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03781453
Enrollment
498
Registered
2018-12-19
Start date
2019-04-01
Completion date
2020-02-07
Last updated
2020-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Behavior, Health Knowledge, Attitudes, Practice, Men, Mental Health Wellness 1

Brief summary

With funding from the Alberta Ministry of Labour (Grant #095244772), a program called POWERPLAY (www.powerplayatwork.com), designed to promote men's health at work, will be evaluated in workplaces in Alberta.

Detailed description

In year 1, this project includes two main research components: 1. A pragmatic (real world) study will be conducted employing a quasi-experimental (not a randomized controlled trial), before and after design to evaluate the effectiveness of the POWERPLAY program. 2. An integrated set of research activities (systematic review, sleep behaviors and consultation groups) will be used to provide the basis for developing recommendations for promoting sleep health in male-dominated workplaces, and inform the development and testing of a POWERPLAY sleep health module (REST-UP) in Year 2.

Interventions

BEHAVIORALPOWERPLAY

Employees from participating worksites will be invited to completed surveys prior to and following implementation of a workplace wellness program (called POWERPLAY)

Sponsors

University of British Columbia
CollaboratorOTHER
Athabasca University
CollaboratorOTHER
University of Alberta
CollaboratorOTHER
Newcastle University
CollaboratorOTHER
University of Melboune
CollaboratorUNKNOWN
University Technology Sydney
CollaboratorUNKNOWN
Joan Bottorff
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Quasi-experimental, pre-post study design

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Men employed in participating workplaces, full-time or part-time, in any position within the organizations.

Exclusion criteria

* Although females may participate in the POWERPLAY program and surveys, they will not be included in the evaluation.

Design outcomes

Primary

MeasureTime frameDescription
Moderate to Vigorous Physical Activity4 monthsMinutes of Moderate to Vigorous physical activity will be assessed using self-report at baseline and follow-up using the Godin Leisure-Time Exercise Questionnaire (Godin & Shephard, 1985). The Godin Leisure-Time Exercise Questionnaire contains three self-report questions that assess both the average frequency and duration (in minutes) of mild, moderate, and vigorous activities during free time over a typical week. Frequency and minutes are multiplied to obtain minutes per week (range from 0 and up). Weekly moderate and vigorous activity minutes will be summed and compared from baseline to follow-up, with higher scores indicating more activity. In addition, a cutoff of 150 minutes in 7 days will be used to classify participants as meeting or not meeting Canadian guidelines for physical activity at baseline and follow-up.
Mental Wellness4 monthsMental well-being will be assessed using the well validated Short Warwick-Edinburgh Mental Well-Being Scale (SWEMWBS) (Haver, Akerjordet, Caputi, Furunes, & Magee, 2015; Tennant et al., 2007) at baseline and follow-up. Participants respond to 7-items (e.g., I've been feeling optimistic about the future) on a 5-point Likert scale ranging from none of the time (1) to all of the time (5), with higher scores reflecting greater mental well-being. The SWEMWBS is scored by summing the score for each of the seven items (possible range 7-35).

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026